Common Issues in Prenatal Care: Gestational Diabetes

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Public Health

Background:

• Gestational diabetes (GDM) affects pregnant individuals, necessitating effective screening and management strategies.
• Two primary screening methods, the 1-step and 2-step approaches, are utilized for GDM detection.
• Early detection and management are crucial for maternal and fetal well-being.

Purpose of the Study:

• To outline current screening protocols for gestational diabetes.
• To detail management strategies, including lifestyle modifications and pharmacotherapy.
• To provide guidance on delivery timing and postpartum follow-up for GDM patients.

Main Methods:

• Screening via 1-step (75-g, 2-hr OGTT) or 2-step (50-g, 1-hr glucose challenge test followed by OGTT if positive) oral glucose tolerance tests (OGTT).
• Management focused on lifestyle modifications, with pharmacologic intervention (insulin, metformin, glyburide) for persistent hyperglycemia.
• Antenatal fetal surveillance and specific delivery timing recommendations based on GDM control.

Main Results:

• Screening is recommended between 24-28 weeks gestation for all pregnant individuals without pre-existing diabetes.
• Lifestyle changes effectively manage GDM in most cases; medication is reserved for persistent hyperglycemia.
• Delivery timing varies based on GDM control: 39 0/7–40 6/7 weeks for diet-controlled, and 39 0/7–39 6/7 weeks for drug-controlled GDM.

Conclusions:

• Gestational diabetes requires timely screening and tailored management, including lifestyle adjustments and potential medication.
• Patients with GDM face an elevated risk of developing type 2 diabetes postpartum, necessitating ongoing monitoring.
• Postpartum screening with OGTT is recommended 4-12 weeks after delivery and periodically thereafter.